A preliminary study on pharmacokinetics of oral indomethacin in premature infants in north India

Indian Journal of Medical Research

Volumn 117, Issue APR., 2003, Pages 164-169

  Sharma, P K ^a   Garg, S R ^a   Narang, A ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Indomethacin; Infants; Patent ductus arteriosus; Pharmacokinetics

Indexed keywords

INDOMETACIN;

AGE; AREA UNDER THE CURVE; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CHILD HOSPITALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOXICITY; FEMALE; GENDER; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INDIA; INDWELLING CATHETER; INFANT; MALE; NEWBORN CARE; PATENT DUCTUS ARTERIOSUS; POPULATION RESEARCH; PREMATURITY; RISK ASSESSMENT; SINGLE DRUG DOSE; SPECTROFLUOROMETRY;

ADMINISTRATION, ORAL; BIRTH WEIGHT; CARDIOVASCULAR AGENTS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INDIA; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; MALE;

EID: 0142074829     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Clyman RI. Medical treatment of patent ductus arteriosus in premature infants. In: Long WA, editor. Fetal and Neonatal Cardiology. Philadelphia: WB Saunders; 1990 p. 682-90.
2. Auld PA. Delayed closure of the ductus arteriosus. J Pediatr 1966; 69 : 61-6.
3. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. New Engl J Med 1982; 306 : 506-10.
4. Rennie JM, Doyle J, Cooke RW. Early administration of indomethacin to preterm infants. Arch Dis Child 1986; 61 : 233-8.
5. Betkerur MV, Yeh TF, Miller K, Glasser RJ, Pildes RS. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981; 68 : 99-102.
6. Roberts LJ II, Morrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's the Pharmacological Basis of Therapeutics, 10th ed. New York: McGraw-Hill Companies, Inc.; 2001 p. 687-731.
7. Evans MA, Bhat R, Vidyasagar D, Vadapalli M, Fisher E, Hastreiter A. Gestational age and indomethacin elimination in the neonate. Clin Pharmacol Ther 1979; 26 : 746-51.
8. Bhat R, Vidyasagar D, Fisher E, Hastreiter A, Ramirez JL, Burns L, et al. Pharmacokinetics of oral and intravenous indomethacin in preterm infants. Dev Pharmacol Ther 1980; 1 : 101-10.
9. Vert P, Bianchetti G, Marchal F, Monin P, Morselli PL. Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus. Eur J Clin Pharmacol 1980; 18 : 83-8.
10. Thalji AA, Carr I, Yeh TF, Raval D, Luken JA, Pildes RS. Pharmacokinetics of intravenously administered indomethacin in premature infants. J Pediatr 1980; 97 : 995-1000.
11. Yaffe SJ, Friedman WF, Rogers D, Lang P, Ragni M, Saccar C. The disposition of indomethacin in preterm babies. J Pediatr 1980; 97 : 1001-6.
12. Friedman CA, Parks BR, Rawson JE, Serwer GA, Anderson PA. Indomethacin and the preterm infant with a patent ductus arteriosus: Relationship between plasma concentration and ductus closure. Dev Pharmacol Ther 1982; 4 : 37-46.
13. Lindquist B, Jensen KM, Johansson H, Hansen T. Effect of concurrent administration of aspirin and indomethacin on serum concentrations. Clin Pharmacol Ther 1974; 15 : 247-52.
14. Gibaldi M, Perrier D. Pharmacokinetics: Absorption Kinetics and Bioavailability, 2nd ed. New York: Marcel Dekker Inc.; 1982 p. 145-98.
15. Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics, 3rd ed. Philadelphia: Lea & Febiger; 1984.
16. Brash AR, Hickey DE, Graham TP, Stahlman MT, Oates JA, Cotton RB. Pharmacokinetics of indomethacin in neonates. Relation of plasma indomethacin levels to response of the ductus arteriosus. New Engl J Med 1981; 305: 67-72.
17. Yeh TF, Achanti B, Patel H, Pildes RS. Indomethacin therapy in premature infants with patent ductus arteriosus-determination of therapeutic plasma levels. Dev Pharmacol Ther 1989; 12: 169-78.
18. Gal P, Gilman JT. Drug disposition in neonates with patent ductus arteriosus. Ann Pharmacother 1993; 27: 1383-8.
19. Yaffe SJ, Juchau MR. Perinatal pharmacology. Annu Rev Pharmacol 1974; 14: 219-38.
20. Loughnan PM, Greenwald A, Purton WW, Aranda JV, Watters G, Neims AH. Pharmacokinetic observations of phenytoin disposition in the newborn and young infant. Arch Dis Child 1977; 52: 302-9.
21. Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 1979; 94: 663-8.
22. Alvan G, Orme M, Bertilsson L, Ekstrand R, Palmer L. Pharmacokinetics of indomethacin. Clin Pharmacol Ther 1975; 18: 364-73.
23. Morselli PL. Clinical pharmacokinetics in neonates. Clin Pharmacokinet 1976; 1: 81-98.
24. Kwan KC, Breault GO, Umbenhauer ER, McMahon FG, Duggan DE. Kinetics of indomethacin absorption, elimination and enterohepatic circulation in man. J Pharmacol Biopharmaceut 1976; 4: 255-80.
25. Bhat R, Vidyasagar D, Vadapalli M, Whalley C, Fisher E, Hastreiter A, et al. Disposition of indometacin in preterm infants. J Pediatr 1979; 95: 313-6.
26. McCarthy JS, Zeis LG, Gelband H. Age-dependent closure of the patent ductus arteriosus by indomethacin. Pediatrics 1978; 62: 706-12.
27. Yanagi RM, Wilson A, Newfeld EA, Aziz KU, Hunt CE. Indomethacin treatment for symptomatic patent ductus arteriosus: A double-blind control study. Pediatrics 1981; 67: 647-52.
28. Friedman Z, Whitman V, Maisels MJ, Berman W Jr, Marks KH, Vesell ES. Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants. J Clin Pharmacol 1978; 18: 272-9.
29. Neal WA, Kyle JM, Mullett MD. Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 1977; 91: 621-3.